Page last updated: 2024-08-18

pyrroles and amoxicillin

pyrroles has been researched along with amoxicillin in 65 studies

Research

Studies (65)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (1.54)29.6817
2010's29 (44.62)24.3611
2020's35 (53.85)2.80

Authors

AuthorsStudies
Bijev, AT; Hung, V1
Bocian, S; Buszewski, B; Ligor, T; Olszowy, P; Szultka, M1
Buszewski, B; Jackowski, M; Szeliga, J; Szultka, M1
Fleissig, Y; Lehman, H; Regev, E1
Horio, A; Kamiya, K; Nishio, E; Tokura, Y1
Asaka, M; Funao, N; Murakami, K; Nishimura, A; Sakurai, Y; Shiino, M1
Ishihara, S; Kawashima, K; Kinoshita, Y1
Gotoda, T; Iwatsuka, K; Kusano, C; Moriyama, M; Suzuki, S1
Hasegawa, S; Nakamura, K; Nishimura, A; Okamoto, H; Sakurai, Y; Shiino, M1
Fukui, K; Hayakawa, Y; Hirata, Y; Isomura, Y; Ito, Y; Koike, K; Matsuo, K; Mochizuki, S; Niikura, R; Okamoto, M; Omae, T; Seto, M; Shichijo, S; Sugimoto, T; Suzuki, H; Suzuki, N; Takano, N; Togo, G; Watabe, H; Yamada, A; Yamamoto, S1
Fujita, M; Graham, DY; Haruma, K; Ishii, M; Kamada, T; Katsumata, R; Matsumoto, H; Murao, T; Nakato, R; Shiotani, A1
Adachi, K; Ebi, M; Funaki, Y; Goji, S; Izawa, S; Kasugai, K; Noda, H; Noguchi, S; Ogasawara, N; Sasaki, M; Tamura, Y; Yamamoto, S; Yoshimine, T1
Kajihara, Y; Mizuki, I; Shimoyama, T1
Eguchi, T; Fujita, M; Fukuchi, T; Hashimura, H; Kanamori, A; Kano, C; Koizumi, A; Matsumoto, K; Momose, K; Okada, A; Shimoyama, K; Tsujimae, M; Yamashita, H1
Hasuda, K; Hattori, M; Ido, Y; Okuda, A; Sakurai, K; Suda, H; Takeichi, T1
Fujisawa, T; Horiuchi, A; Imai, R; Kimura, T; Kiyosawa, K; Kubota, D; Maruyama, M; Matsuda, Y; Miyajima, M; Mori, H; Tanaka, N; Tokutake, K; Wada, S1
Jung, YS; Kim, EH; Park, CH1
Hu, Y; Lu, NH; Zhu, Y2
Amano, H; Arima, I; Fukuchi, T; Ikeda, A; Inokuchi, Y; Ishii, Y; Iwase, S; Iwata, Y; Kanno, M; Kawana, I; Kokawa, A; Komatsu, K; Kondo, M; Kunishi, Y; Kuwashima, H; Maeda, S; Miwa, H; Morimoto, M; Naito, M; Oka, H; Okazaki, H; Saito, T; Sanga, K; Sasaki, T; Shibata, W; Sue, S; Takahashi, D; Tamura, T; Terada, M1
Ando, K; Fujinaga, A; Fujiya, M; Goto, M; Ichiishi, E; Ito, T; Kashima, S; Kawamoto, T; Kohgo, Y; Moriichi, K; Nomura, Y; Okumura, T; Otake, T; Sato, K; Sato, T; Sugano, H; Tanabe, H; Ueno, N; Utsumi, T; Yanagawa, N1
Fujibayashi, S; Fujiya, M; Goto, T; Kashima, S; Moriichi, K; Nomura, Y; Okumura, T; Sakatani, A; Sasajima, J; Tanaka, K; Ueno, N1
Gotoda, T; Ikehara, H; Kusano, C; Moriyama, M; Suzuki, S1
Ando, K; Fujiya, M; Ichiishi, E; Ishizuka, A; Kohgo, Y; Nomura, Y; Ohta, K; Okumura, T; Otake, T; Satoh, K; Tanabe, H; Yoshino, K1
Hayashi, Y; Kobayashi, Y; Lefor, AK; Miura, Y; Osawa, H; Sakamoto, H; Shinozaki, S; Yamamoto, H1
Irie, K; Kaneko, H; Kondo, M; Maeda, S; Sasaki, T; Shibata, W; Sue, S1
Endo, H; Fujimoto, K; Hara, M; Hidaka, H; Kawachi, K; Matsunaga, T; Nakano, R; Sakata, Y; Shimoda, R; Takara, Y; Tsuruoka, N1
Fukuba, N; Ishitobi, H; Kinoshita, Y; Kobayashi, Y; Komazawa, Y; Kusunoki, M; Nagaoka, M; Shizuku, T; Takahashi, Y; Yuki, M1
Kiyotoki, S; Nishikawa, J; Sakaida, I1
Fukui, K; Hayashi, S; Higaki, Y; Inada, M; Matsubara, T; Mukai, K; Nakajima, S; Nakamatsu, D; Nishida, T; Okamoto, A; Osugi, N; Sugimoto, A; Takahashi, K; Tomita, R; Tsujii, Y; Yamamoto, M1
Dohi, O; Hara, T; Inada, Y; Inoue, K; Itoh, Y; Iwai, N; Kagawa, K; Komaki, T; Konishi, H; Naito, Y; Oka, K; Okuda, T; Tsuji, T1
Argueta, EA; Moss, SF1
Furuta, T; Hamaya, Y; Higuchi, T; Iwaizumi, M; Kagami, T; Miyajima, H; Osawa, S; Sugimoto, K; Suzuki, T; Tani, S; Umemura, K; Uotani, T; Yamade, M1
Adachi, K; Ebi, M; Funaki, Y; Hijikata, Y; Izawa, S; Kasugai, K; Ogasawara, N; Sasaki, M; Shinmura, T; Yamaguchi, Y1
Asahina, A; Kikuchi, S; Nobeyama, Y; Saeki, H1
Hayashi, Y; Kobayashi, Y; Lefor, AK; Osawa, H; Sakamoto, H; Shinozaki, S; Yamamoto, H1
Furuta, T; Hamaya, Y; Higuchi, T; Iwaizumi, M; Kagami, T; Miyajima, H; Osawa, S; Sugimoto, K; Suzuki, T; Tani, S; Umemura, K; Yamade, M1
Fujioka, Y; Hashiguchi, K; Imamura, I; Kakiuchi, T; Kawakubo, H; Matsuo, M; Mizoe, A; Nakayama, A; Okuda, M; Yamaguchi, D; Yamamoto, K1
Ando, T; Handa, O; Horie, R; Imamoto, E; Itoh, Y; Murakami, T; Ose, T; Sendo, R; Suzuki, N1
Hayakawa, Y; Hirata, Y; Koike, K; Niikura, R; Shichijo, S; Yamada, A1
Gotoda, T; Horii, T; Ichijima, R; Ikehara, H; Kusano, C; Suzuki, S1
Graham, DY; Lu, H; Shiotani, A1
Akiyama, J; Cho, H; Hisada, Y; Iwata, E; Kawazoe, M; Kimura, K; Kobayakawa, M; Komori, S; Mishima, S; Nagata, N; Okahara, K; Okubo, H; Shimada, T; Shimomura, A; Shiroma, S; Takasaki, Y; Uemura, N; Watanabe, K; Yanagisawa, N; Yokoi, C1
Graham, DY; Howden, CW1
Eto, H; Gotoda, T; Ichijima, R; Ikehara, H; Ito, H; Kawabe, K; Kawamura, M; Kusano, C; Nakahara, M; Suzuki, S; Yoda, Y1
Bhatia, S; Chung, H; Huh, KY; Kim, YK; Lee, S; Nakaya, R; Takanami, Y; Yu, KS1
Deguchi, H; Fukuhara, S; Kamitani, T; Yamamoto, Y; Yamazaki, H1
Gotoda, T; Horii, T; Ichijima, R; Ikehara, H; Kusano, C; Shibuya, H; Suzuki, S; Takano, C1
Borody, TJ; Clancy, A; Dawson, MVM; Gunaratne, AW; Hamblin, H; Magat, AJMC; Tu, J1
Gotoda, T; Horii, T; Ichijima, R; Ikehara, H; Kusano, C; Ogura, K; Sugita, T; Suzuki, S; Takano, C1
Bunchorntavakul, C; Buranathawornsom, A1
Chiu, CT; Chong, CF; Chung, WC; Gu, L; Hou, X; Kudou, K; Meng, F; Sha, W; Wang, J; Zhang, S1
He, C; Hu, Y; Li, NS; Lu, NH; Ouyang, YB; Peng, C; Shu, X; Xie, C; Xie, Y; Xu, X; Zhu, Y; Zhu, ZH3
Ang, D; Ang, TL; Chan, YH; Koo, SH; Krishnasamy-Balasubramanian, JK; Kumar, R; Kwek, AB; Li, JW; Lin, KW; Ong, PJ; R, R; Soon, GH; Tan, CK; Tan, TY; Tan, Y; Tan, YJ; Wong, YJ1
Chey, WD; Howden, CW; Hunt, BJ; Laine, L; López, LJ; Mégraud, F1
Hu, Y; Lu, NH; Ouyang, Y; Wang, M; Xu, YL; Zhu, Y1
Fallone, CA1
Cheng, H; Gao, W; Li, Y; Teng, G; Wang, C; Xu, Y1
Hu, Y; Lu, NH1
Ang, D1
Hu, W; Sun, Y; Yue, L1
Liu, L; Nahata, MC1
Ding, YM; Han, ZX; Ji, R; Li, YY; Lin, BS; Zhang, WL1

Reviews

12 review(s) available for pyrroles and amoxicillin

ArticleYear
Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.
    Alimentary pharmacology & therapeutics, 2017, Volume: 46, Issue:2

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2017
Novel and Effective Therapeutic Regimens for
    Frontiers in cellular and infection microbiology, 2017, Volume: 7

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Mutation; Prevalence; Probiotics; Proton Pump Inhibitors; Pyrroles; Rifabutin; Sulfonamides; Tetracycline; Tetracycline Resistance

2017
Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature.
    Digestive diseases and sciences, 2017, Volume: 62, Issue:11

    Topics: Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Remission Induction; Retrospective Studies; Sulfonamides; Time Factors; Treatment Outcome

2017
Efficacy of Vonoprazan for Helicobacter pylori Eradication.
    Internal medicine (Tokyo, Japan), 2020, Jan-15, Volume: 59, Issue:2

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2020
Treatment of Helicobacter pylori.
    Current opinion in gastroenterology, 2019, Volume: 35, Issue:6

    Topics: Amoxicillin; Anti-Infective Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Prognosis; Proton Pump Inhibitors; Pyrroles; Risk Assessment; Severity of Illness Index; Sulfonamides; Treatment Outcome

2019
Effectiveness and Safety of Vonoprazan versus Proton Pump Inhibitors for Second-Line Helicobacter pylori Eradication Therapy: Systematic Review and Meta-Analysis.
    Digestion, 2021, Volume: 102, Issue:3

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome

2021
Recent progress in Helicobacter pylori treatment.
    Chinese medical journal, 2020, Feb-05, Volume: 133, Issue:3

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Probiotics; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Vitamins

2020
Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance.
    Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:5

    Topics: Amoxicillin; Antimicrobial Stewardship; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Failure; Treatment Outcome

2021
Amoxicillin-vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
    Journal of gastroenterology and hepatology, 2022, Volume: 37, Issue:9

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Potassium; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome

2022
Effectiveness and safety of vonoprazan-based regimens compared with those of proton pump inhibitor (PPI)-based regimens as first-line agents for Helicobacter pylori: a meta-analysis of randomized clinical trials.
    European journal of clinical pharmacology, 2023, Volume: 79, Issue:2

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Treatment Outcome

2023
Vonoprazan With Amoxicillin or Amoxicillin and Clarithromycin for the Treatment of
    The Annals of pharmacotherapy, 2023, Volume: 57, Issue:10

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Treatment Outcome

2023
Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis.
    Digestion, 2023, Volume: 104, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Pyrroles; Treatment Outcome

2023

Trials

14 trial(s) available for pyrroles and amoxicillin

ArticleYear
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.
    Gut, 2016, Volume: 65, Issue:9

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome

2016
Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study.
    Advances in therapy, 2016, Volume: 33, Issue:9

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Healthy Volunteers; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome

2016
Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line
    Canadian journal of gastroenterology & hepatology, 2017, Volume: 2017

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Single-Blind Method; Sulfonamides; Treatment Outcome

2017
Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children.
    Journal of gastroenterology, 2018, Volume: 53, Issue:6

    Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome

2018
Randomized trial of vonoprazan-based versus proton-pump inhibitor-based third-line triple therapy with sitafloxacin for Helicobacter pylori.
    Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:4

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastritis; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sulfonamides; Treatment Failure; Treatment Outcome

2019
Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial.
    Helicobacter, 2020, Volume: 25, Issue:3

    Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diarrhea; Drug Therapy, Combination; Female; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Male; Probiotics; Pyrroles; Sulfonamides

2020
Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication.
    British journal of clinical pharmacology, 2022, Volume: 88, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Pyrroles; Sulfonamides; Treatment Outcome

2022
Randomized clinical trial: 7-day vonoprazan-based versus 14-day omeprazole-based triple therapy for Helicobacter pylori.
    Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:12

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2021
Vonoprazan non-inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients.
    Journal of gastroenterology and hepatology, 2022, Volume: 37, Issue:7

    Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Neoplasm Recurrence, Local; Pyrroles; Sulfonamides

2022
Optimization of vonoprazan-amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study.
    Helicobacter, 2022, Volume: 27, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter; Helicobacter Infections; Helicobacter pylori; Humans; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome

2022
Clinical trial: seven-day vonoprazan- versus 14-day proton pump inhibitor-based triple therapy for first-line Helicobacter pylori eradication.
    Alimentary pharmacology & therapeutics, 2022, Volume: 56, Issue:3

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome

2022
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial.
    Gastroenterology, 2022, Volume: 163, Issue:3

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome; United States

2022
Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Fatty Acids, Volatile; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Pyrroles; RNA, Ribosomal, 16S; Sulfonamides

2022
Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication.
    Helicobacter, 2022, Volume: 27, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Microbiota; Proton Pump Inhibitors; Pyrroles; RNA, Ribosomal, 16S; Sulfonamides

2022

Other Studies

39 other study(ies) available for pyrroles and amoxicillin

ArticleYear
Synthesis and antimicrobial activity of new pyrrolecarboxylic acid derivatives of ampicillin and amoxicillin.
    Arzneimittel-Forschung, 2001, Volume: 51, Issue:8

    Topics: Acylation; Amoxicillin; Ampicillin; Animals; Carboxylic Acids; Gram-Positive Bacteria; Lethal Dose 50; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Pyrroles; Spectrophotometry, Infrared

2001
A novel approach to the rapid determination of amoxicillin in human plasma by solid phase microextraction and liquid chromatography.
    The Analyst, 2011, Jun-21, Volume: 136, Issue:12

    Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Humans; Polymers; Pyrroles; Solid Phase Microextraction; Thiophenes

2011
Development of novel molecularly imprinted solid-phase microextraction fibers and their application for the determination of antibiotic drugs in biological samples by SPME-LC/MS(n).
    Analytical and bioanalytical chemistry, 2012, Volume: 403, Issue:3

    Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Daptomycin; Humans; Linezolid; Mass Spectrometry; Molecular Imprinting; Oxazolidinones; Polymers; Pyrroles; Sensitivity and Specificity; Solid Phase Microextraction; Thiophenes

2012
Sunitinib related osteonecrosis of jaw: a case report.
    Oral surgery, oral medicine, oral pathology and oral radiology, 2012, Volume: 113, Issue:3

    Topics: Actinomyces; Actinomycosis; Amoxicillin; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma, Renal Cell; Clavulanic Acid; Female; Humans; Indoles; Kidney Neoplasms; Mandible; Mandibular Diseases; Middle Aged; Molar, Third; Osteonecrosis; Pyrroles; Sunitinib; Tooth Extraction; Tooth Socket

2012
Erythema multiforme caused by triple therapy with amoxicillin, clarithromycin and vonoprazan for Helicobacter pylori.
    The Journal of dermatology, 2016, Volume: 43, Issue:3

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Erythema Multiforme; Female; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2016
Successful eradication of Helicobacter pylori infection with vonoprazan-based triple therapy after failure of PPI-based triple therapy.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:6

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2016
The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy.
    The American journal of gastroenterology, 2016, Volume: 111, Issue:7

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Monitoring; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Retrospective Studies; Sulfonamides; Treatment Outcome

2016
Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice.
    Journal of digestive diseases, 2016, Volume: 17, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Feasibility Studies; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome; Young Adult

2016
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:11

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; RNA, Ribosomal, 23S; Sulfonamides; Treatment Outcome; Urea

2016
A Novel Potassium-Competitive Acid Blocker Improves the Efficacy of Clarithromycin-containing 7-day Triple Therapy against Helicobacter pylori.
    Journal of gastrointestinal and liver diseases : JGLD, 2016, Volume: 25, Issue:3

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Remission Induction; Retrospective Studies; Sulfonamides; Time Factors; Treatment Outcome

2016
Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication.
    Scandinavian journal of gastroenterology, 2017, Volume: 52, Issue:2

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Retrospective Studies; Sulfonamides

2017
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori.
    Digestion, 2016, Volume: 94, Issue:4

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome

2016
Comparative study: Vonoprazan and proton pump inhibitors in
    World journal of gastroenterology, 2017, Jan-28, Volume: 23, Issue:4

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Patient Safety; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome

2017
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication.
    Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Young Adult

2017
Second-line therapy for Helicobacter pylori eradication causing antibiotic-associated hemorrhagic colitis.
    Annals of clinical microbiology and antimicrobials, 2017, Aug-14, Volume: 16, Issue:1

    Topics: Abdominal Pain; Aged; Amoxicillin; Biopsy; Colitis; Colon; Colonoscopy; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Hemorrhage; Humans; Klebsiella oxytoca; Metronidazole; Mucous Membrane; Pyrroles; Rare Diseases; Sulfonamides

2017
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
    Annals of clinical microbiology and antimicrobials, 2018, Jun-28, Volume: 17, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides

2018
Pre-treatment with proton pump inhibitors decreases the success of primary Helicobacter pylori eradication using a vonoprazan-based regimen.
    The Kaohsiung journal of medical sciences, 2018, Volume: 34, Issue:8

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome

2018
Smoking and Drinking Did Not Increase the Failure of Therapeutic Helicobacter pylori Eradication by Vonoprazan, Clarithromycin, and Amoxicillin.
    Digestion, 2019, Volume: 99, Issue:2

    Topics: Aged; Alcohol Drinking; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Smoking; Sulfonamides; Treatment Failure

2019
Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for Helicobacter pylori Eradication.
    Internal medicine (Tokyo, Japan), 2019, Jun-01, Volume: 58, Issue:11

    Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Odds Ratio; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome

2019
A Triple-Drug Blister-Packaged Drug with Vonoprazan Improves First-Line Eradication of Helicobacter pylori in Elderly Patients: A Retrospective Propensity Score-Matched Cohort Study.
    Digestion, 2020, Volume: 101, Issue:5

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Packaging; Drug Therapy, Combination; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Propensity Score; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome; Young Adult

2020
Helicobacter pylori eradication increases the serum high density lipoprotein cholesterol level in the infected patients with chronic gastritis: A single-center observational study.
    PloS one, 2019, Volume: 14, Issue:8

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Atherosclerosis; Cholesterol, HDL; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lipid Metabolism; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome

2019
Dual Therapy with Vonoprazan and Amoxicillin Is as Effective as Triple Therapy with Vonoprazan, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori.
    Digestion, 2020, Volume: 101, Issue:6

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome

2020
Vonoprazan-Based Triple-Therapy Could Improve Efficacy of the Tailored Therapy of Helicobacter pylori Infection.
    Journal of gastrointestinal and liver diseases : JGLD, 2019, Dec-09, Volume: 28, Issue:4

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome

2019
Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication.
    The Journal of dermatology, 2020, Volume: 47, Issue:3

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Erythema Multiforme; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sex Factors; Stevens-Johnson Syndrome; Sulfonamides

2020
Influence of clarithromycin on the bactericidal effect of amoxicillin in patients infected with clarithromycin-resistant strains of
    Gut, 2020, Volume: 69, Issue:11

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter pylori; Humans; Japan; Pyrroles; Sulfonamides

2020
Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan.
    Helicobacter, 2020, Volume: 25, Issue:4

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome

2020
Efficacy and safety of a new rifabutin-based triple therapy with vonoprazan for refractory Helicobacter pylori infection: A prospective single-arm study.
    Helicobacter, 2020, Volume: 25, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Rifabutin; Sulfonamides

2020
Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan.
    Journal of gastroenterology, 2020, Volume: 55, Issue:10

    Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Students; Sulfonamides; Treatment Outcome

2020
Vonoprazan-based triple therapy is effective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility.
    Journal of gastroenterology, 2020, Volume: 55, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome; Young Adult

2020
Recent Developments Pertaining to H. pylori Infection.
    The American journal of gastroenterology, 2021, 01-01, Volume: 116, Issue:1

    Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Pyrroles; Rifabutin; Stomach Neoplasms; Sulfonamides; Tetracycline; Treatment Outcome

2021
Impact of body size on first-line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy.
    Helicobacter, 2021, Volume: 26, Issue:2

    Topics: Amoxicillin; Anti-Bacterial Agents; Body Size; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome

2021
Impact of Vonoprazan Triple-Drug Blister Packs on H. pylori Eradication Rates in Japan: Interrupted Time Series Analysis.
    Advances in therapy, 2021, Volume: 38, Issue:7

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Interrupted Time Series Analysis; Japan; Pharmaceutical Preparations; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome

2021
Lower impact of vonoprazan-amoxicillin dual therapy on gut microbiota for Helicobacter pylori eradication.
    Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:12

    Topics: Amoxicillin; Anti-Bacterial Agents; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2021
Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study.
    Helicobacter, 2021, Volume: 26, Issue:5

    Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Australia; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome

2021
Long term impact of vonoprazan-based Helicobacter pylori treatment on gut microbiota and its relation to post-treatment body weight changes.
    Helicobacter, 2021, Volume: 26, Issue:6

    Topics: Amoxicillin; Anti-Bacterial Agents; Body Weight; Drug Therapy, Combination; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2021
The Current Role of Vonoprazan in Helicobacter pylori Treatment.
    Gastroenterology, 2022, Volume: 163, Issue:3

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2022
Eradication rate and safety of a "simplified rescue therapy": 14-day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in eradication: A real-world, retrospective clinical study in Ch
    Helicobacter, 2022, Volume: 27, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Potassium; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome; Urease

2022
Letter: a promising Helicobacter pylori regimen - vonoprazan-based therapy.
    Alimentary pharmacology & therapeutics, 2022, Volume: 56, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2022
Letter: a promising Helicobacter pylori regimen-vonoprazan-based therapy. Author's reply.
    Alimentary pharmacology & therapeutics, 2022, Volume: 56, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2022